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doi:10.1016/j.ejvs.2008.05.003Abstract Objectives: To determine the influence of haemodialysis on the poor healing of
ischaemic ulcers in end-stage renal failure patients regardless of successful revascularization.
Materials and methods: We investigated the microscopic findings of subcutaneous small
vessels in the amputated limbs of 78 patients (27 diabetic/haemodialysis, 26 diabetic/non-
haemodialysis and 25 non-diabetic/non-haemodialysis patients) who underwent foot/toe or
limb amputation because of ischaemic foot ulcers in the period between 1998 and 2006. All
the haemodialysis patients were diabetic. Multivariate logistic analysis was conducted to iden-
tify important clinical factors related to the histological findings.
Results: Marked medial thickening was observed in both small veins and arteries in diabetic
patients compared with non-diabetic patients. In diabetics, there was significant medial thick-
ening of small veins, which was greater in haemodialysis patients than in non-haemodialysis
patients (Dunnett test, P< 0.05). Multivariate analysis indicated that haemodialysis treatment
(odds ratio 14.12, P< 0.01), ABI value (odds ratio 5.41, P< 0.01) and poor stump wound heal-
ing (odds ratio 6.19, PZ 0.03) were important factors related to medial thickening of small
veins.
Conclusions: Our data suggest that medial thickening of small veins, or phlebosclerosis, might
affect the healing of ischaemic ulcers in end-stage renal failure, although the strong influence
of diabetes cannot be ignored.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.81 3 5800 8735.
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In patients with end-stage renal failure the management of
ischaemic ulcers is challenging. The ulcers are often
persistent and slow to improve despite aggressive surgical
treatment including distal pedal bypass or endovascular
therapy.1e3d by Elsevier Ltd. All rights reserved.
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explain why it is difficult to achieve healing of ulcers in end-
stage renal disease. Haemodialysis patients are known to
have severe arterial calcification. Several previous studies
suggested that these calcified vessels are the main cause of
non-healing ischaemic ulcers. However, luminal obstruction
of small arteries in end-stage renal failure is not always
associated with calcification.4
As most patients with haemodialysis are diabetic, the
healing process of ischaemic ulcers should be affected by
diabetic microangiopathy as well as atherosclerosis. Fur-
thermore, diabetic ulcers are susceptible to infection, which
also leads to the non-healing characteristics in end-stage
renal failure. One study demonstrated a type of micro-
angiopathy in the skin, so-called dermopathy.5 Another study
supported the presence of a functional impairment of the
microcirculation in diabetes.6 Stewart et al. demonstrated
that functional impairment of endothelial cells leads to
a decrease of skin perfusion in haemodialysis patients.7
Hinchliffe et al. reported that haemodialysis has a persistent
influence on transcutaneous oxygen tension.8 However, the
degree to which renal failure affects the healing process of
diabetic ulcers in patients with end-stage renal failure
remains unclear.
In terms of the microstructure of the skin, morphological
alteration of the stroma has been demonstrated in haemo-
dialysis patients. However, the precise mechanisms by
which these changes lead to poor healing have not yet
been delineated.
Thus, there has been little information about whether
the non-healing ulcers of haemodialysis patients are due
only to the influences of comorbid conditions such as
diabetes and arteriosclerosis, or are related to haemodial-
ysis itself. We studied the histological findings to examine
the influence of haemodialysis on wound healing in end-
stage renal failure.
Materials and Methods
Patients
We studied a total of 78 patients who underwent foot/toe
or limb amputation because of ischaemic foot ulcers caused
by diabetes or atherosclerosis at the Department of Surgery
in Teikyo University Ichihara Hospital in the period between
January 1998 and March 2006. The patient group consisted
of 53 consecutive diabetic patients (27 haemodialysis
patients and 26 non-haemodialysis patients) and 25 age-
and sex-matched control patients. These patients included
59 men and 19 women with a mean age of 63.6 years (39e
86 years). All the haemodialysis patients had type 2
diabetes and had received haemodialysis treatment three
times a week in the dialysis centre of our hospital for
a mean period of 6.0 years, ranging from 3e240 months.
The control group consisted of patients without diabetes
and end-stage renal failure who underwent foot/toe or limb
amputation because of arterial obstruction during the same
study period. They served as age- and sex-matched controls
to determine the influences of diabetes and haemodialysis.
Among the haemodialysis patients, 8 patients under-
went vascular reconstruction. They included 7 cases offemoro-popliteal bypass (2 cases of below-knee bypass)
and one of popliteal- pedal bypass. On the other hand, the 8
non-haemodialysis diabetic patients who underwent vascu-
lar reconstruction included 6 cases of femoro-popliteal
bypass (one case of below-knee distal bypass) and 2 of
femoro-popliteal bypass with iliac stenting. Furthermore,
among the non-haemodialysis/non-diabetic patients, 12
patients underwent vascular reconstruction. Among those
patients, femoro-popliteal bypass was the dominant pro-
cedure. A total of 7 patients underwent femoro-popliteal
bypass. The other 5 patients included 3 cases of femoro-
femoral cross-over bypass, one of aorto-femoral bypass, and
one of aorto-femoral bypass with femoro-popliteal bypass.
Poor wound healing was defined as delayed removal of
sutures more than 3 weeks after amputation because of any
condition interfering with wound healing such as infection
or insufficient blood flow.
ABI measurement was performed in a routine manner. As
the perfusion pressure of the foot was usually low in the
study patients, it was possible to measure ABI even in
patients with arterial calcification. In several patients, we
assessed ABI values following leg elevation.
Culture of swabs taken from ulcers and wounds was
routinely performed at the initial presentation and several
times during the course of treatment, even if concomitant
infection was not suspected.
Tissue specimens
The histological samples consisted of 27 samples from the
haemodialysis patients and 51 from the non-haemodialysis
patients. All the samples were obtained from the adjacent
skin proximal to the ischaemic foot/toe or limb, where the
skin was not macroscopically affected by degenerative
changes due to necrosis. Tissue specimens were blindly
examined by two independent pathologists for thickening
and calcification of subcutaneous arteries and veins smaller
than the digital vessels, with a diameter of 40e70 mm.
Assessment of histological findings
Each entire section was observed under a microscope at
high magnification (200) using hematoxylin & eosin and
van Gieson’s staining. Wall thickening of the arteries and
veins was evaluated in five randomly selected fields.
Evaluation was carried out for each layer of the vessels,
i.e. tunica intima and tunica media. Thickening of the layer
was scored according to four grades from 0 (none) to 3
(greatest). We regarded complete obstruction of a vessel
due to thickening of the wall as grade 3. The final score for
each layer was defined as the mean of the total scores in
arteries or veins counted in five fields. Two pathologists
reached agreement on the final evaluation, which they
made for each tissue specimen in order to overcome
selection bias.
Calcification of small vessels was also assessed using
similar scoring with four grades from 0 to 3. In terms of the
calcification of small vessels, the score for the whole wall,
rather than for each layer, was obtained.
We assumed that the spatial distribution of subcuta-
neous small vessels is uniform as long as the samples are
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samples included apparent ischaemic degenerative lesions
microscopically, the site of counting was always selected
in the intermediate zone between the viable and ischae-
mic part, in order to minimize the influence of ischaemic
damage of the samples. With this manipulation, it was
assumed that the score would reflect the degree of wall
thickening directly affecting non-healing of the ulcer. The
influence of proximal arterial obstruction on the morpho-
logical changes was analyzed statistically using ABI
values.
Statistics
Data were analyzed with SAS version 9.1 (SAS Institute,
Cary, NC). Univariate analysis was performed initially to
evaluate the possible importance of clinical variables. The
relevant variables with univariate P values less than 0.10
were selected for inclusion in the initial step of logistic
analysis. Comparison was performed using Student’s t-test
or Mann-Whitney U test. Comparisons among proportions
were made using Pearson’s chi-squared statistic to identify
variables possibly correlated with pathological findings.
Fisher’s exact test for 2 2 tables was used for small
samples.
Logistic analysis was used to identify important variables
relating to the histological findings among the background
clinical data obtained from the hospital records. Those dataTable 1 Demographics of patients with limb/toe amputation b
Variable Haemodialysis
patientsc
(nZ 27)
Age (SD) 61.3 (10.4)
Male sex 20 (74.1%)
Duration of ulcerb 3.0
MRSA/Psedomonas infection 11 (40.7%)
ABI (SD) 0.25 (0.22)
Current smoking 19 (70.4%)
Bypass surgery 8 (29.6%)
Poor stump healing after amputation 9 (33.3%)
Concurrent triopathya 25 (92.6%)
Hypertension 20 (74.1%)
History of ischaemic heart disease 15 (55.6%)
Arrhythmia 3 (11.1%)
History of cerebrovascular disease 9 (33.3%)
Drug therapy
ACE inhibitor 8 (30.0%)
Ca2þ channel antagonist 16 (59.3%)
Nitrates 16 (59.3%)
Anti-platelet drug 19 (70.4%)
Warfarin 1 (3.7%)
Prostaglandin analogue 26 (96.3%)
Digoxin 1 (3.7%)
ABI, ankle brachial pressure index.
a Retinopathy, neuropathy and nephropathy.
b Values are presented as median.
c All haemodialysis patients were diabetic.included the cause of end-stage renal failure, age, sex,
current smoking status, associated diabetes mellitus, asso-
ciated hypertension, concurrent atrial fibrillation, previous
history of ischaemic heart disease or cerebrovascular
disease, and administered drugs. A previous history of
ischaemic heart disease included previous myocardial in-
farction (as documented by electrocardiogram, enzymes,
or history), angina, or positive findings of non-invasive
studies (myocardial scintigraphy or echocardiography). A
previous history of cerebrovascular disease included a his-
tory of abrupt onset of neurological deficit regardless of its
duration. The ankle brachial index (ABI) before amputation
was also included in the analysis. Data relating to age and
duration of symptoms were classified into categorical
variables.
Variables that were significantly associated with histo-
logical findings were entered into a logistic regression
model, and the variables were assessed to determine which
ones were independently associated with the histological
findings, using stepwise manipulation. The level of signif-
icance was set at a P value less than 0.05.
Ethical guidelines
The human research review committee of Teikyo University
Ichihara Hospital approved the protocol of the present
study, and informed consent for permission to use histo-
logical samples was given by each patient.ecause of peripheral arterial occlusive disease
Non-haemodialysis
diabetic patients
(nZ 26)
Non-haemodialysis/
non-diabetic patients
(nZ 25)
P value
63.6 (9.3) 64.0 (8.4) 0.14
17 (65.4%) 22 (88.0%) 0.17
2.5 2.6 0.90
11 (42.3%) 13 (52.0%) 0.68
0.42 (0.42) 0.15 (0.27) 0.01
16 (61.5%) 16 (64.0%) 0.78
8 (30.8%) 12 (48.0%) 0.31
10 (38.5%) 7 (28.0%) 0.73
12 (46.2%) 0 (0.0%) <0.01
16 (61.5%) 18 (72.0%) 0.57
3 (11.5%) 5 (20.0%) <0.01
1 (3.9%) 7 (28.0%) 0.04
7 (26.9%) 10 (40.0%) 0.61
5 (19.2%) 4 (16.0%) 0.46
8 (30.8%) 12 (48.0%) 0.11
5 (19.2%) 9 (36.0%) 0.01
12 (46.2%) 16 (64.0%) 0.18
1 (3.9%) 3 (12.0%) 0.44
22 (84.6%) 24 (96.0%) 0.31
1 (3.9%) 4 (16.0%) 0.27
Table 2 Level of amputation in study patients
Patient group Haemodialysis
patientsa (nZ 27)
Non-haemodialysis
diabetic patients (nZ 26)
Non-haemodialysis/
non-diabetic patients (nZ 25)
Above-knee amputation 7 2 11
Below-knee amputation 11 9 12
Foot/toe amputation 9 15 2
Values are number of patients.
Fisher’s exact test, PZ 1.00; haemodialysis vs. non-haemodialysis patients.
Fisher’s exact test, P< 0.01; diabetics vs. non-diabetics patients.
a All haemodialysis patients were diabetic.
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The patient demographics are presented in Table 1. All the
groups were matched for age and sex. All of them had is-
chaemic ulcers that were proved to be contaminated by
culture studies, and over 40% of the patients in each group
had MRSA or Pseudomonas infection. However, there was
no statistically significant difference in the frequencies of
infection with these bacteria between the groups.
The prevalence of a previous history of ischaemic heart
disease was higher in haemodialysis patients than in non-
haemodialysis patients. The amputations in non-haemodialysis
patients consisted of 13 above-knee, 21 below-knee and 17
foot/toe amputations, while those in haemodialysis patients
consisted of 7 above-knee, 11 below-knee, and 9 foot/toe
amputations. The distribution of amputation was different
between the diabetics and non-diabetics (Fisher exact test,
PZ .0012). There was a high frequency ofmajor amputation
above the ankle in non-diabetic compared with diabetic
patients. However, the distribution of amputation did not
differ significantly between the haemodialysis and non-
haemodialysis patient groups (PZ 1.0000) (Table 2).
Results of histological assessment
Before assessment of the pathological results, the agree-
ment of two pathologists was measured using kappa
coefficient for each observation. The values were 0.87,
0.84, 0.82 and 0.84 for arterial intima, arterial media,Table 3 Score of wall thickening in small arteries and veins
Studied microvessels
and their layers
Haemodialysis
patientsd (nZ 27)
Non-haemodial
diabetic patien
Small arteries
Intima 0.69 0.68 0.62 0.64
Media 1.17 0.85b 1.08 0.78
Small veins
Intima 0.46 0.76 0.48 0.74
Media 1.24 1.05b,c 0.77 0.90c
Data are mean SD.
a Analysis of variance.
b Dunnett test, P< 0.01; haemodialysis vs. non-haemodialysis/non-d
c Dunnett test, P< 0.05; haemodialysis vs. non-haemodialysis diabe
d All haemodialysis patients were diabetic.venous intima, and venous media, respectively (data not
shown). A high degree of agreement was shown between
the two pathologists.
The mean score of medial thickening of the small
arteries was significantly higher in the haemodialysis group
than in the non-haemodialysis/non-diabetic group, while
the scores of intimal wall thickening did not show a statis-
tically significant difference. However, the score of medial
thickening of the arteries in haemodialysis patients was
similar to that in non-haemodialysis diabetic patients.
Regarding small veins, the mean score of medial thickening
in haemodialysis patients was significantly higher than that
in both non-haemodialysis diabetics and non-haemodialysis/
non-diabetic patients (Table 3) (Figs. 1, 2).
There was no apparent calcification of small veins in
either haemodialysis or diabetic patients, while calcification
of small arteries was significantly greater in haemodialysis
patients than in both non-haemodialysis diabetics and non-
haemodialysis/non-diabetic patients (Mann-Whitney test,
P< 0.05).
Important clinical factors related to thickening of
arterial wall
Multivariate analysis indicated that thickening of the
arterial wall was related to associated diabetic triopathy
(retinopathy, neuropathy and nephropathy), previous
history of cerebrovascular disease and previous history of
ischaemic heart disease (Table 4).ysis
ts (nZ 26)
Non-haemodialysis/
non-diabetic patients (nZ 25)
P-valuea
0.48 0.60 0.51a
0.52 0.64b <0.01a
0.08 0.40 0.06a
0.28 0.56b <0.01a
iabetic patients.
tic patients.
Figure 1 Typical photomicrographs of small vessels in non-
haemodialysis, non-diabetic patients. Elastica von Gieson
staining shows maintenance of three layers, i.e. intima, media,
and adventitia, in an arteriole (left lower corner) and a small
vein (right upper corner).
Table 4 Significant factors for medial thickening of small
arteries by logistic regression analysis
Variable Df Odds ratio (95% CI) P value
Concurrent triopathya 1 15.308
(2.539e92.303)
<0.01
0Z no
1Z yes
History of
cerebrovascular
disease
1 19.013
(3.581e100.952)
<0.01
0Z no
1Z yes
History of ischaemic
heart disease
1 0.125
(0.020e0.792)
0.02
0Z no
1Z yes
Df; number of degrees of freedom.
a Retinopathy, neuropathy and nephropathy.
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venous wall
Multivariate analysis indicated that thickening of the
venous wall was related to haemodialysis treatment, ABI
value 0.3 and poor postoperative wound healing (Table 5).
Discussion
The healing process of ischaemic ulcers is impaired by
various underlying conditions in diabetic patients. Those
conditions include decreased blood perfusion in large and
small vessels due to atherosclerosis, susceptibility to in-
fection, and recurrent trauma due to diabetic neuropathy
or the sequelae of cerebrovascular disease. Above all,
diabetic patients with associated end-stage renal failureFigure 2 Typical photomicrographs of small veins showing
medial thickening in haemodialysis patients (arrow).have poor wound healing in spite of successful bypass
surgery.1e3 The most important finding of this study is
that the mean score of medial thickening of small veins
was significantly higher in haemodialysis patients than in
non-haemodialysis patients.
Several histological studies have investigated the mech-
anisms of poor wound healing in diabetics. One previous
study demonstrated marked PAS (periodic acid-Schiff stain)
deposition in the basal membrane of capillaries.9 Another
recent study showed increased apical and non-apical dila-
tation, hemorrhagic extravasations and branching of nail
capillaries.10 The histopathological features of the diabetic
foot include increased inflammatory elements, matrix
alterations, vessel disruption, inflammation, and debris.11
In contrast to these morphological changes, many studies
published over the last decade have revealed that func-
tional rather than structural changes are more responsible
for the poor wound healing, through impaired ability to
vasodilate in response to injury.3,12 The histological findings
in the present study are not consistent with those previous
reports, showing morphological changes in both small veins
and arteries, but not in capillaries. These findings suggest
the possibility that the histological changes in small veins
involve distinct pathogenetic mechanisms from diabetic
microangiopathy or so-called diabetic foot.Table 5 Significant factors for medial thickening of small
veins by logistic regression analysis
Variable Df Odds ratio (95% CI) P value
Haemodialysis treatment 1 14.12 (2.71e73.52) <0.01
0Z no
1Z yes
ABI value 1 5.41 (1.12e26.11) <0.01
0Z above 0.3
1Z equal or less than 0.3
Poor wound healing 1 6.19 (1.41e27.29) 0.03
0Z no
1Z yes
Df; number of degrees of freedom.
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were caused by haemodialysis itself or by one of the
diabetic sequelae, as all the haemodialysis patients were
diabetic in the present study, although there is a tendency
for thickening of small vessels to be more apparent in
haemodialysis patients. To overcome this problem, we
conducted multivariate analysis to confirm the indepen-
dence of the haemodialysis factor in venous wall thicken-
ing. The results of logistic analysis indicated that
haemodialysis was an independent factor for venous medial
thickening (or phlebosclerosis), while the association of
diabetic triopathy (retinopathy, neuropathy and nephropa-
thy) and atherosclerotic complications were significant
variables related to medial thickening of the small arteries.
These results justify our conclusion that haemodialysis is an
independent variable for venous sclerosis, and venous
thickening appears to be related more closely to the poor
wound healing in haemodialysis patients. Although the
morphological changes in the small veins may be secondary,
there is a possibility that non-healing ulcers in haemodial-
ysis may be caused by venular congestion or venous
hypertension,13 such as occurs in stasis ulcers.
The present study has a limitation in that our series was
not matched for the level of amputation and comorbid
conditions such as previous history of ischaemic heart
disease, although all the patient groups were matched for
age and sex. These patient characteristics may induce more
advanced arteriosclerosis in haemodialysis patients. In fact,
haemodialysis patients are well known to have greater
sclerotic comorbidity. Although advanced arteriosclerosis
might have influenced the outcome of the present study,
atherosclerosis is not usually associated with phleboscle-
rosis. Therefore, it is not likely that artherosclerosis would
have affected the development of fibrosis of the small
veins.
There is a possibility that reduced perfusion of the foot
due to proximal obstructive lesions may induce thickening
of distal vessels. Anvar and colleagues14 examined by trans-
mission electron microscopy skin biopsies taken from the is-
chaemic foot, and suggested that the stromal haemorrhage
and degeneration caused by ‘‘gaps’’ between elongated
oedematous endothelial cells probably signifies a terminal
stage of critical limb ischemia. Another study by Coats15
pointed out functional inconsistencies between the proxi-
mal and distal arterioles in critical limb ischemia. These re-
sults are consistent with ours in the sense that perfusion
status may influence the vessels of the foot not only func-
tionally but also morphologically. However, neither of the
studies specified the changes in small veins or venules, un-
like the present study. Thus, we believe that the influence
of proximal hemodynamics on distal vessels has not been
delineated in previous studies. To overcome this problem,
we used ABI measurement in statistical analysis. Although
toe pressure reflects the perfusion status of the foot more
precisely, we used ABI values because of the high frequency
of necrotic changes of the toes. We attempted to minimize
the bias in ABI measurement in non-compressible arteries
by means of leg raising manipulation. Based on the results
of the above mentioned analysis, we believe that the influ-
ence of the perfusion status of the foot is relatively small,
if any, and a reduction of the perfusion alone cannot induce
themicroscopic changes in small veins observed in our study.There are several possible causes leading to wall
thickening of small veins.16 First, persistent infection may
induce perivascular fibrosis surrounding small veins. Venous
stasis ulcers may have a similar pathogenesis to non-healing
ulcers in haemodialysis patients, although many previous
studies have focused on morphological changes in the capil-
laries.17,18 Secondarily, recurrent injury due to diabetic
neuropathy might induce fibrosis of the venous wall. In
fact, the prevalence of a previous history of cerebrovascu-
lar disease in haemodialysis patients was higher than that in
non-haemodialysis patients in our series. Loss of sensation
of the extremity due to cerebrovascular events may relate
to these findings. Thirdly, there is a possibility that use of
insulin may relate to thickening of the venous media. It is
well known that insulin causes overgrowth and wall thick-
ening of the retinal microvessels, acting as a growth
hormone-like substance.19 Furthermore, insulin is reported
to stimulate vasoconstriction.20,21 Our microscopic findings
could be consistent with those observed in diabetic retinop-
athy, although there are some reports that the thickness of
the vessel wall in diabetes does not differ according to the
use of insulin.22 The high incidence of retinopathy in pa-
tients with non-healing ulcers may support this speculation.
Lastly, hypotension during haemodialysis treatment may in-
duce vasoconstriction in the skin. Haemodialysis patients
often experience recurrent hypotension during haemodial-
ysis treatment, although it is not likely that hypotension
affects the lower extremity alone. Haemodialysis patients
also experience recurrent platelet activation by the filter
as well as hemodynamic changes, which are additional
influences of haemodialysis besides the uremic state.
Although it is not easy to determine which of the above-
mentioned factors are most important in the venous
sclerosis observed in this particular study, the significant in-
fluences of diabetes can not be ruled out.
In conclusion, our data suggest that medial thickening of
small veins, or phlebosclerosis might be one of the
significant factors affecting the healing of ischaemic ulcers
in end-stage renal failure, although the strong influence of
diabetes cannot be ignored. Further study is needed to
determine the main cause of venous wall thickening, with
a non-diabetic haemodialysis group serving as a control.
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